Enhanced ocular anti-aspergillus activity of tolnaftate employing novel cosolvent-modified spanlastics: formulation, statistical optimization, kill kinetics, ex vivo trans-corneal permeation, in vivo histopathological and susceptibility study

HIGHLIGHTS

  • who: Diana Aziz and collaborators from the Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, University have published the paper: Enhanced Ocular Anti-Aspergillus Activity of Tolnaftate Employing Novel Cosolvent-Modified Spanlastics: Formulation, Statistical Optimization, Kill Kinetics, Ex Vivo Trans-Corneal Permeation, In Vivo Histopathological and Susceptibility Study, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of /2022/
  • what: The study was performed three times and the results were presented as mean ± SD.
  • how: Twelve male albino rabbits (2-3 kg) were used in the study.

SUMMARY

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?